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Items for this week’s EPI Update include: 
 
• Middle East Respiratory Syndrome Coronavirus 
• Doxycycline shortage 
• CDC releases new H7N9 testing recommendations 
• Meeting announcements and training opportunities 
 
Middle East Respiratory Syndrome Coronavirus 
55 laboratory-confirmed cases of Middle East Respiratory Syndrome Coronavirus 
(MERS-Co V) have been reported to the World Health Organization (WHO). No cases 
have been reported in the United States. The Centers of Disease Control and 
Prevention (CDC) is working closely with WHO to understand the public health risk.  
For recommendations and guidance on MERS-Co V, visit 
www.cdc.gov/coronavirus/MERS/index.html. 
 
Doxycycline shortage 
The Food and Drug Administration (FDA) has released an update on the doxycycline 
shortage initially reported in January, 2013. Some manufacturers continue to report a 
shortage of doxycycline in some forms and doses. For additional information, visit 
www.fda.gov/Drugs/DrugSafety/DrugShortages/default.htm. 
 
CDC releases new H7N9 testing recommendations 
The CDC has issued new recommendations for specimen collection, processing and 
testing for patients that may be infected with influenza H7N9. As of June 3, 2013, more 
than 130 cases of human infection with H7N9 have been reported in mainland China 
and Taiwan. No cases have been reported in the United States at this time. For 
information on testing, visit  www.cdc.gov/flu/avianflu/h7n9/specimen-collection.htm. 
 
 
Meeting announcements and training opportunities 
None 
 
Have a healthy and happy week! 
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